Prevention of Recurrent Staphylococcal Skin Infections With Low-Dose Oral Clindamycin Therapy

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 18, 1988, Pages 2682-2685

  Klempner, Mark S ^a   Styrt, Barbara ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN;

ABSCESS; ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, ORAL; ADULT; AGED; CLINDAMYCIN; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MIDDLE AGE; NEUTROPHILS; RANDOM ALLOCATION; RECURRENCE; STAPHYLOCOCCAL SKIN INFECTIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0023724201     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410180090035     Document Type: Article

References (24)

1. Fekety FR: The epidemiology and prevention of staphylococcal infection. Medicine 1964;43:593.
2. Nahmias AJ, Shulman J: Epidemiology of staphylococci, in Cohen JD (ed): The Staphylococci. New York, John Wiley & Sons Inc, 1972, pp 486502.
3. Weinstein HJ: The relationship between the nasal staphylococcal carrier state and the incidence of postoperative complications. N Engl J Med 1959;260:1303-1308.
4. White A: Increased infection rates in heavy nasal carriers of coagulase-positive staphylococci. Antimicrob Agents Chemother 1963;3:667-670.
5. Tullock LG: Nasal carriage in staphylococcal skin infections. Br Med J 1954;2:912-913.
6. Martin AM, Clunie GJ, Tonkin RW, et al.: The etiology and management of shunt infections in patients on intermittent hemodialysis. Proc Eur Dial Transplant Assoc 1967;4:67-72.
7. Goldblum SE, Reed WP, Ulrich JA, et al.: Staphylococcal carriage and infections in hemodialysis patients. Dial Transplant 1978;7:1140-1148.
8. Kirmani N, Tuazon CU, Murray HW, et al.: Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 1978;138:1657-1659.
9. Klempner MS, GallinJI: Isolation and functional characterization of human neutrophil subpopulations. Blood 1978;51:659-669.
10. Georgilis K, Schaeffer C, Dinarello CA, et al.: Human recombinant interleukin-1-beta has no effect on intracellular calcium or on functional responses of human neutrophils. J Immunol 1987;135:3403-3407.
11. Allen JC: The diabetic as a compromised host, in Allen JC (ed): Infection and the Compromised Host. Baltimore, Williams & Wilkins, 1981, p 229.
12. Donabedian H, Gallin JI: The hyperimmunoglobulin E recurrent infection (Job’s) syndrome: A review of the NIH experience and the literature. Medicine 1983;63:195-208.
13. Wheat LJ, Kohler RB, White A: Prevention of infections of skin and skin structures. Am J Med 1984;76:187-190.
14. Yu VL, Goetz A, Wagener M, et al.: Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986;315:91-96.
15. Hedstrom SA: Treatment and prevention of recurrent staphylococcal furunculosis: Clinical and bacteriological follow-up. Scand J Infect Dis 1985;17:55-58.
16. Solberg CO: A study of carriers of Staphylococcus aureus with special regard to quantitative bacterial estimates. Acta Med Scand 1965;436:1-96.
17. Boris M, Sellers TF, Eichenwald HF, et al.: Bacterial interference: Protection of adults against nasal Staphylococcus aureus infection after colonization with heterologous S aureus strain. AJDC 1964;108:252.
18. Aly R, Shinefield H, Maibach H: Bacterial interference among Staphylococcus aureus strains, in Bacterial Interference. Boca Raton, Fla, CRC Press Inc, 1982, pp 13-23.
19. Drutz DJ, Van Nay HH, Schaffner W, et al.: Bacterial interference in the therapy of recurrent staphylococcal infections: Multiple abscesses due to the implantation of the 502A strain of staphylococcus. N Engl J Med 1965;275:1161-1165.
20. Wheat LJ, Kohler RB, Luft FC, et al.: Long term studies on the effect of rifampin on nasal carriage of coagulase-positive staphylococci. Rev Infect Dis 1983;5:S459-S462.
21. Sande MA, Mandell GL: Effect of rifampin on nasal carriage of Staphylococcus aureus. Antimicrob Agents Chemother 1975;7:294-297.
22. Mandell GL, Vest TK: Killing of intraleukocyte Staphylococcus aureus by rifampin: In vitro and in vivo studies. J Infect Dis 1972;125:486-490.
23. Klempner MS, Styrt B: Clindamycin uptake by human neutrophils. J Infect Dis 1981;144:472-479.
24. Styrt B, Ho JL, Klempner MS: Interaction between antimicrobial agents and phagocytes: In vitro animal and human studies, in Klempner MS, Styrt B, Ho JL (eds): Phagocytes & Disease. Lancaster, England, MTP Press Ltd, in press.